Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2025-12-25 @ 7:07 PM
Study NCT ID:
NCT03410004
Status:
UNKNOWN
Last Update Posted:
2018-01-25
First Post:
2018-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-12
First Submit QC Date:
None
Study First Post Date:
2018-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-23
Last Update Post Date:
2018-01-25
Last Update Post Date Type:
ACTUAL